Tag: ESC 2023
Switching to NOACs in frail AF patients associated with more bleeding...
Switching vitamin K antagonist (VKA) treatment to a non-vitamin K antagonist oral anticoagulant (NOAC) in frail elderly patients with atrial fibrillation (AF) is associated...
ESC 2023: AF ablation improves outcomes in end-stage heart failure patients
Atrial fibrillation (AF) ablation is associated with lower rates of death, urgent heart transplantation or left ventricular assist device (LVAD) implantation compared with medical...
ESC 2023: Anticoagulation should not be used in patients with AHRE...
Oral anticoagulation in patients with atrial high rate episodes (AHRE) increases bleeding without reducing a composite outcome of stroke, systemic embolism or cardiovascular death.
This...
ESC 2023: Study finds link between fitness and incidence of AF...
Physical fitness is linked with a lower likelihood of developing atrial fibrillation (AF) and stroke, a study of more than 15,000 people, to be...